Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Understanding the roles of testosterone and the androgen receptor during cardiomyogenesis
FY 2013-14
Summary
Heart disease is attributable to a large number of illness and death worldwide. Although there is a variety of heart disease, cases involving the death or damage of the heart muscle, which occurs for instance, in a heart attack or congenital heart disease, renders the individual’s heart at a reduced functional capacity, thus contributing greatly to quantity and quality of life. Stem cells are undifferentiated cells which have the ability to replicate and remain in an undifferentiated state as well to differentiate into almost every cell type in the human body. In this case, the ultimate goal would be to differentiate the stem cells into cardiac muscle and replace a patient’s damaged or dead heart muscle so their heart function increases. Although there is great potential with stems more research is needed to obtain methods leading to less variation in cell population during differentiation, and to gain a better understating of the molecular details of the differentiation.
One strategy which shows promise to increase the number of cardiac muscle cells (cardiomyocytes) is the treatment of the stem cells with testosterone, a commonly known androgen steroid. The addition of testosterone to differentiating mouse embryonic stem cells (mES cells) resulted in a greater number of cardiomyocytes compared to mES cells not treated with testosterone. Although all cells in the body have the same genetic code (DNA), the expression of these genes varies significantly between different cell types and an increase in cardiomyogenesis correlates with an increase in the cardiac genes. The increase in select genes can be moderated via certain proteins called transcription factors which bind to DNA and transcribe it into RNA which is further translated to a protein. Thus, one theory testosterone is thought to act is by binding and activating the androgen receptor (AR) which is a transcription factor thus allowing an increase in cardiac genes leading to an increase in cardiomyogenesis.
As testosterone and the AR have implications in cardiomyogenesis, further experiments should be done to gain a better understanding of their mechanism of function. One experiment proposed is to determine the genomic interactions between the AR and other potential targets occurring in mES cells during differentiation into cardiomyocytes (with specific focus on other transcription factors). Furthermore, as testosterone treatment has also resulted in the increase in pacemaker cell markers, the effects of testosterone pertaining to the maturation of cardiomyocytes will be assessed as well. It will be important to find a method of differentiating stem cells in a manner where it is know which cardiac cell type will be the outcome. With the proposed research it is hoped the knowledge gained will lead to getting a more pure population of cardiomyocytes needed for future therapeutical considerations.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311716
Name
Bosiljcic Neven
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding the roles of testosterone and the androgen receptor during cardiomyogenesis
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Androgen Receptor; Cardiomyocyte Maturation; Cardiomyogenesis; Chip-Seq; Gene Regulation; Rna-Seq; Stem Cells; Testosterone
Abstract
Heart disease is attributable to a large number of illness and death worldwide. Although there is a variety of heart disease, cases involving the death or damage of the heart muscle, which occurs for instance, in a heart attack or congenital heart disease, renders the individual’s heart at a reduced functional capacity, thus contributing greatly to quantity and quality of life. Stem cells are undifferentiated cells which have the ability to replicate and remain in an undifferentiated state as well to differentiate into almost every cell type in the human body. In this case, the ultimate goal would be to differentiate the stem cells into cardiac muscle and replace a patient’s damaged or dead heart muscle so their heart function increases. Although there is great potential with stems more research is needed to obtain methods leading to less variation in cell population during differentiation, and to gain a better understating of the molecular details of the differentiation.
One strategy which shows promise to increase the number of cardiac muscle cells (cardiomyocytes) is the treatment of the stem cells with testosterone, a commonly known androgen steroid. The addition of testosterone to differentiating mouse embryonic stem cells (mES cells) resulted in a greater number of cardiomyocytes compared to mES cells not treated with testosterone. Although all cells in the body have the same genetic code (DNA), the expression of these genes varies significantly between different cell types and an increase in cardiomyogenesis correlates with an increase in the cardiac genes. The increase in select genes can be moderated via certain proteins called transcription factors which bind to DNA and transcribe it into RNA which is further translated to a protein. Thus, one theory testosterone is thought to act is by binding and activating the androgen receptor (AR) which is a transcription factor thus allowing an increase in cardiac genes leading to an increase in cardiomyogenesis.
As testosterone and the AR have implications in cardiomyogenesis, further experiments should be done to gain a better understanding of their mechanism of function. One experiment proposed is to determine the genomic interactions between the AR and other potential targets occurring in mES cells during differentiation into cardiomyocytes (with specific focus on other transcription factors). Furthermore, as testosterone treatment has also resulted in the increase in pacemaker cell markers, the effects of testosterone pertaining to the maturation of cardiomyocytes will be assessed as well. It will be important to find a method of differentiating stem cells in a manner where it is know which cardiac cell type will be the outcome. With the proposed research it is hoped the knowledge gained will lead to getting a more pure population of cardiomyocytes needed for future therapeutical considerations.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bosiljcic, Neven
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~